BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10745057)

  • 1. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.
    Heinz A; Jones DW; Mazzanti C; Goldman D; Ragan P; Hommer D; Linnoila M; Weinberger DR
    Biol Psychiatry; 2000 Apr; 47(7):643-9. PubMed ID: 10745057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.
    Willeit M; Stastny J; Pirker W; Praschak-Rieder N; Neumeister A; Asenbaum S; Tauscher J; Fuchs K; Sieghart W; Hornik K; Aschauer HN; Brücke T; Kasper S
    Biol Psychiatry; 2001 Jul; 50(1):8-12. PubMed ID: 11457418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
    Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
    Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels.
    Little KY; McLaughlin DP; Zhang L; Livermore CS; Dalack GW; McFinton PR; DelProposto ZS; Hill E; Cassin BJ; Watson SJ; Cook EH
    Am J Psychiatry; 1998 Feb; 155(2):207-13. PubMed ID: 9464199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype.
    van Dyck CH; Malison RT; Staley JK; Jacobsen LK; Seibyl JP; Laruelle M; Baldwin RM; Innis RB; Gelernter J
    Am J Psychiatry; 2004 Mar; 161(3):525-31. PubMed ID: 14992979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.
    Shioe K; Ichimiya T; Suhara T; Takano A; Sudo Y; Yasuno F; Hirano M; Shinohara M; Kagami M; Okubo Y; Nankai M; Kanba S
    Synapse; 2003 Jun; 48(4):184-8. PubMed ID: 12687637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype influences in vivo dopamine transporter availability in human striatum.
    Heinz A; Goldman D; Jones DW; Palmour R; Hommer D; Gorey JG; Lee KS; Linnoila M; Weinberger DR
    Neuropsychopharmacology; 2000 Feb; 22(2):133-9. PubMed ID: 10649826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence.
    Heinz A; Goldman D; Gallinat J; Schumann G; Puls I
    Psychopharmacology (Berl); 2004 Aug; 174(4):561-70. PubMed ID: 15148564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders.
    Collier DA; Stöber G; Li T; Heils A; Catalano M; Di Bella D; Arranz MJ; Murray RM; Vallada HP; Bengel D; Müller CR; Roberts GW; Smeraldi E; Kirov G; Sham P; Lesch KP
    Mol Psychiatry; 1996 Dec; 1(6):453-60. PubMed ID: 9154246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.
    Mann JJ; Huang YY; Underwood MD; Kassir SA; Oppenheim S; Kelly TM; Dwork AJ; Arango V
    Arch Gen Psychiatry; 2000 Aug; 57(8):729-38. PubMed ID: 10920459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promotor-linked polymorphic region.
    Glatz K; Mössner R; Heils A; Lesch KP
    J Neurochem; 2003 Sep; 86(5):1072-8. PubMed ID: 12911615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression.
    Hranilovic D; Stefulj J; Schwab S; Borrmann-Hassenbach M; Albus M; Jernej B; Wildenauer D
    Biol Psychiatry; 2004 Jun; 55(11):1090-4. PubMed ID: 15158428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior.
    Hallikainen T; Saito T; Lachman HM; Volavka J; Pohjalainen T; Ryynänen OP; Kauhanen J; Syvälahti E; Hietala J; Tiihonen J
    Mol Psychiatry; 1999 Jul; 4(4):385-8. PubMed ID: 10483057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism].
    Heinz A; Jones DW; Bissette G; Hommer D; Ragan P; Knable M; Wellek S; Linnoila M; Weinberger DR
    Pharmacopsychiatry; 2002 Jul; 35(4):127-34. PubMed ID: 12163982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter gene polymorphisms in alcohol dependence.
    Thompson MD; Gonzalez N; Nguyen T; Comings DE; George SR; O'Dowd BF
    Alcohol; 2000 Oct; 22(2):61-7. PubMed ID: 11113619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study.
    Schuckit MA; Mazzanti C; Smith TL; Ahmed U; Radel M; Iwata N; Goldman D
    Biol Psychiatry; 1999 Mar; 45(5):647-51. PubMed ID: 10088053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of dopamine transporter binding availability by genotype: a preliminary report.
    Jacobsen LK; Staley JK; Zoghbi SS; Seibyl JP; Kosten TR; Innis RB; Gelernter J
    Am J Psychiatry; 2000 Oct; 157(10):1700-3. PubMed ID: 11007732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
    Johann M; Bobbe G; Putzhammer A; Wodarz N
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.